Back to Directory
Tabimorelin
Growth Hormone SecretagoguesOrally active ghrelin mimetic studied for growth hormone deficiency and frailty.
Key Benefits
- ✓Oral GH stimulation
- ✓Investigated for frailty
- ✓Appetite enhancement
Dosing Information
Dosage Range
Research only
Frequency
Discontinued
Typical Duration
N/A
Detailed Protocol
Development discontinued. Was studied as oral formulation.
About Tabimorelin
Tabimorelin is an orally bioavailable peptidomimetic ghrelin receptor agonist investigated for elderly frailty and GH deficiency. Clinical development discontinued despite showing GH-stimulating effects.
Research Notes
Phase 2 trials showed GH stimulation but development discontinued. Oral bioavailability was key feature.
Potential Side Effects
- •Development discontinued
Always consult with a healthcare professional before starting any peptide therapy.